Oncopeptides SEK 1.1 billion private placing of new shares
We advised Oncopeptides on the private placement of shares
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Prometheus Biosciences $218.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Crocs $350 million senior notes offering
We advised the initial purchasers on the high-yield notes offering
Fidelity National Information Services $5.5 billion senior notes offering
The investment-grade offering was coupled with cash tender offers for outstanding debt
Nissin Foods ¥23.9 billion secondary offering
We advised the managers on the sale of TSE-listed shares by multiple Japanese shareholders
Commonwealth Bank of Australia cash tender offers
We advised the dealer managers on the debt tender offers
Pacific Gas and Electric $2.4 billion first mortgage bonds offering
The high-yield offering included multiple tranches of first mortgage bonds
Vontier $1.6 billion notes offering
We advised the initial purchasers on the investment-grade debt offering
Development Bank of Japan program update and $520 million senior notes offering
We advised DBJ on its global MTN program update and sustainability bond offering
NTT Finance concurrent $8 billion and €2 billion senior notes offerings
We advised the initial purchasers on the guaranteed senior notes offerings